Abstract:Roux-en Y gastric bypass (RYGB) surgery is among the most effective treatments for obesity, with the majority of weight lost as fat.Recent studies in humans and rats have demonstrated that RYGB alters gut microbial composition.Given the recently recognized link among diet, the gut microbiota, and host adiposity, we hypothesized that alterations in the gut microbiota after RYGB may contribute to the effects of this operation on the regulation of energy balance.16S rRNA pyrosequencing of bacterial DNA isolated from fecal samples revealed dramatic changes in gut microbial composition in diet-induced obese (DIO) mice that had undergone RYGB and were maintained on a 60% fat (kcal) diet, as compared to SHAM-operated (SO) animals maintained on the same diet.These effects occurred within one week after surgery and are characterized by multiple changes in microbial ecology, including a substantially increased prevalence of Proteobacteria.Weight loss induced by caloric restriction (weightmatched SO; WMS) did not show the same alterations in fecal microbiota as RYGB but were more similar to ad libitum fed SO animals, indicating that the observed changes in microbial ecology are specific to the surgical manipulation itself.Consistent with this conclusion, RYGB caused similar changes in the gut microbiota in non-obese animals maintained on a normal chow diet (14% fat; kcal).To assess the contribution of the RYGB-modified microbiota to the therapeutic effects of RYGB, we colonized germ free (GF) mice with cecal contents from either RYGB-treated or SO donor mice.GF recipients of SO donor cecal contents (SHAM-R) had 35% greater visceral adipose tissue than uninnoculated GF mice.In contrast, GF recipients of RYGB-treated donor cecal contents (RYGB-R) had 2% less visceral adipose tissue than the uninnoculated GF controls.The RYGB-R reconstituted mice had 27% less visceral adipose tissue than the SHAM-R reconstituted mice.RYGB-R mice also had 22% less visceral adipose tissue than GF mice colonized with cecal contents from WMS donors, suggesting that changes in gut microbial regulation of host adiposity after RYGB are independent of surgery-induced changes in body weight.These observations suggest that the alteration in microbial composition after RYGB contributes to the profound changes in energy balance and diminished adiposity induced by this operation.Elucidating the mechanisms by which altered gut microbiota exert these effects on host metabolic pathways will increase our understanding of the role of the gut on metabolic function more generally, revealing novel regulatory mechanisms that could be exploited to develop new, more effective nonsurgical therapies for obesity and related metabolic disorders.

Gastric bypass elicits persistent gut adaptation and unique diabetes remission‐related metabolic gene regulation

The human gut microbiota contributes to type-2 diabetes non-resolution 5-years after Roux-en-Y gastric bypass

A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass

Roux-en-Y Gastric Bypass Compared to Equivalent Diet Restriction: Mechanistic Insights into Diabetes Remission.

Metabolomics Study of Roux-En-Y Gastric Bypass Surgery (rygb) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry

RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine

Continued Diabetes Remission Despite Weight Recurrence: Gastric Bypass Long-Term Metabolic Benefit

Roux-en-Y Gastric Bypass Improved Insulin Resistance Via Alteration of the Human Gut Microbiome and Alleviation of Endotoxemia

Alterations of DNA Methylation Profile in Proximal Jejunum Potentially Contribute to the Beneficial Effects of Gastric Bypass in a Diabetic Rat Model.

Roux-en-Y Gastric Bypass Surgery of Morbidly Obese Patients Induces Swift and Persistent Changes of the Individual Gut Microbiota

Roux-en-Y gastric bypass-induced perturbative changes in microbial communities and metabolic pathways in rats

Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats

Changes of Serum Lipopolysaccharide, Inflammatory Factors, and Cecal Microbiota in Obese Rats with Type 2 Diabetes Induced by Roux-en-Y Gastric Bypass

2008-P: Roux-en-Y Gastric Bypass Surgery Can Modulate ER Stress and Inflammation on Subcutaneous Adipose Tissue in Nondiabetic Patients with Obesity

Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model.

Contribution of Endogenous Glucagon-Like Peptide-1 to Changes in Glucose Metabolism and Islet Function in People with Type 2 Diabetes Four Weeks after Roux-en-Y Gastric Bypass (RYGB).

Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study

RNA Sequencing of Intestinal Enterocytes Pre- and Post-Roux-en-Y Gastric Bypass Reveals Alteration in Gene Expression Related to Enterocyte Differentiation, Restitution, and Obesity with Regulation by Schlafen 12

Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.

518 Patch Clamp Recordings Reveal Paracellular (tight Junction) Ion Channels

Effect of Roux-En-Y Gastric Bypass on the Remission of Type 2 Diabetes: A 3-Year Study in Chinese Patients with A Bmi < 30 Kg/M(2)